EMAIL THIS PAGE TO A FRIEND

Food chemistry

Hapten synthesis, monoclonal antibody production and development of a competitive indirect enzyme-linked immunosorbent assay for erythromycin in milk.


PMID 25308648

Abstract

Erythromycin is an antibiotic used extensively in veterinary practice worldwide for treatment, prevention and growth promotion. In this work, monoclonal antibodies (Mabs) against erythromycin were produced and used to develop a competitive indirect enzyme-linked immunosorbent assay (ciELISA) for the determination of erythromycin in milk. A novel carboxyphenyl derivative of erythromycin (ERO-CMO) was synthesized and conjugated with bovine serum (BSA) for use as the immunogen or ovalbumin (OVA) as the coating antigen. Four hybridoma cell lines were isolated, which produced Mabs that competed with erythromycin. The 6C1 and 5B2 Mabs had IC50 values for erythromycin of 14.40 and 0.94 μg L(-)(1), respectively. These Mabs demonstrated high cross-reactivity to the macrolides containing 14-membered rings, but not to oleandomycin. No cross-reactivity was observed for 12 macrolides that contained 15 or 16-membered lactone rings or for 2 pleuromutilins. The ciELISA developed using the 5B2 Mab afforded recovery values that ranged from 76.9% to 85.7% with only a 10-fold sample dilution prior to analysis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

75199
Azithromycin, analytical standard
C38H72N2O12
Y0000306
Azithromycin, European Pharmacopoeia (EP) Reference Standard
C38H72N2O12
1046056
Azithromycin, United States Pharmacopeia (USP) Reference Standard
C38H72N2O12 · 2H2O
Y0000637
Azithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
C38H72N2O12
Y0000641
Azithromycin for system suitability, European Pharmacopoeia (EP) Reference Standard
C38H72N2O12
1046067
Azithromycin Identity, United States Pharmacopeia (USP) Reference Standard
C38H72N2O12
C9742
Clarithromycin, ≥95% (HPLC)
C38H69NO13
PHR1038
Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material
C38H69NO13
1134379
Clarithromycin, United States Pharmacopeia (USP) Reference Standard
C38H69NO13
Y0000320
Clarithromycin, European Pharmacopoeia (EP) Reference Standard
C38H69NO13
A3487
Clarithromycin, ≥98% (HPLC)
C38H69NO13
Y0000321
Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
C38H69NO13
1134390
Clarithromycin Identity, United States Pharmacopeia (USP) Reference Standard
C38H69NO13
1046078
Desosaminylazithromycin, United States Pharmacopeia (USP) Reference Standard
C30H58N2O9
45674
Erythromycin, tested according to Ph.Eur.
C37H67NO13
PHR1039
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
C37H67NO13
E1300000
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
C37H67NO13
1242000
Erythromycin, United States Pharmacopeia (USP) Reference Standard
C37H67NO13
E8755
Erythromycin ethyl succinate
C43H75NO16
1245008
Erythromycin ethyl succinate, United States Pharmacopeia (USP) Reference Standard
C43H75NO16
E1500000
Erythromycin ethyl succinate, European Pharmacopoeia (EP) Reference Standard
C43H75NO16
23191
Isobutyl chloroformate, purum, ≥98.0% (GC)
C5H9ClO2
177989
Isobutyl chloroformate, 98%
C5H9ClO2
59983
Josamycin, ≥98.0% (UV)
C42H69NO15
Y0000041
Josamycin, European Pharmacopoeia (EP) Reference Standard
C42H69NO15
Y0001315
Josamycin for peak identification, European Pharmacopoeia (EP) Reference Standard
C42H69NO15
R4393
Roxithromycin, ≥90% (HPLC)
C41H76N2O15
R1500000
Roxithromycin, European Pharmacopoeia (EP) Reference Standard
C41H76N2O15
90781
Tributylamine, puriss. plus, ≥99.5% (GC)
C12H27N
90780
Tributylamine, puriss. p.a., ≥99.0% (GC)
C12H27N